Logo image of AVAC

Avalon Acquisition Inc (AVAC) Stock Fundamental Analysis

NASDAQ:AVAC - Nasdaq - US05338E1010 - Common Stock - Currency: USD

9.1  +0.2 (+2.25%)

After market: 9.67 +0.57 (+6.26%)

Fundamental Rating

1

Taking everything into account, AVAC scores 1 out of 10 in our fundamental rating. AVAC was compared to 0 industry peers in the Unkown industry. The financial health of AVAC is average, but there are quite some concerns on its profitability. AVAC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AVAC was profitable.
AVAC had a negative operating cash flow in the past year.
AVAC Yearly Net Income VS EBIT VS OCF VS FCFAVAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA 2.35%
ROE 2.48%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVAC Yearly ROA, ROE, ROICAVAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 -2 4 -4 -6

1.3 Margins

AVAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AVAC Yearly Profit, Operating, Gross MarginsAVAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

5

2. Health

2.1 Basic Checks

AVAC has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for AVAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AVAC Yearly Shares OutstandingAVAC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 5M 10M 15M 20M 25M
AVAC Yearly Total Debt VS Total AssetsAVAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 12.96 indicates that AVAC is not in any danger for bankruptcy at the moment.
There is no outstanding debt for AVAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.96
ROIC/WACCN/A
WACCN/A
AVAC Yearly LT Debt VS Equity VS FCFAVAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.21 indicates that AVAC may have some problems paying its short term obligations.
A Quick Ratio of 0.21 indicates that AVAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.21
AVAC Yearly Current Assets VS Current LiabilitesAVAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

AVAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.72%.
EPS 1Y (TTM)-31.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AVAC is valuated quite expensively with a Price/Earnings ratio of 45.50.
Compared to an average S&P500 Price/Earnings ratio of 27.50, AVAC is valued quite expensively.
Industry RankSector Rank
PE 45.5
Fwd PE N/A
AVAC Price Earnings VS Forward Price EarningsAVAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVAC Per share dataAVAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AVAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Avalon Acquisition Inc

NASDAQ:AVAC (6/7/2023, 8:06:15 PM)

After market: 9.67 +0.57 (+6.26%)

9.1

+0.2 (+2.25%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change-99.99%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap236.88M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 45.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB 1.15
EV/EBITDA N/A
EPS(TTM)0.2
EY2.2%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS7.9
TBVpS7.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.35%
ROE 2.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.21
Altman-Z 12.96
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-260.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-159.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-159.62%
OCF growth 3YN/A
OCF growth 5YN/A